Complete financial analysis of Perimeter Medical Imaging AI, Inc. (PYNKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perimeter Medical Imaging AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Shenzhen China Bicycle Company (Holdings) Limited (000017.SZ) Income Statement Analysis – Financial Results
- Formuepleje – Obligationer (FPIOBL.CO) Income Statement Analysis – Financial Results
- Silla Co.,Ltd (004970.KS) Income Statement Analysis – Financial Results
- 4imprint Group plc (FRRFF) Income Statement Analysis – Financial Results
- Sino-Thai Engineering and Construction Public Company Limited (STEC-R.BK) Income Statement Analysis – Financial Results
Perimeter Medical Imaging AI, Inc. (PYNKF)
About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403.53K | 132.77K | 11.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 197.11K | 32.14K | 6.30K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 206.42K | 100.63K | 5.04K | -47.57K | -51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 51.15% | 75.79% | 44.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 6.83M | 5.48M | 4.50M | 468.31K | 643.35K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.12M | 5.45M | 7.89M | 8.84M | 7.51M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 4.96M | 4.84M | 3.67M | 122.94K | 36.78K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.68M | 10.28M | 11.56M | 8.96M | 7.54M | 135.62K | 123.44K | 137.17K | 184.42K |
| Other Expenses | 0.00 | 463.68K | 3.57K | 629.17K | 376.57K | 20.42K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.51M | 16.22M | 16.06M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Cost & Expenses | 21.58M | 16.25M | 16.07M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Interest Income | 0.00 | 0.00 | 10.36K | 6.90K | 4.65K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 104.93K | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 614.70K | 1.04M | 93.84K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -13.28M | -11.72M | -15.95M | -6.11M | -7.01M | -115.20K | -123.44K | -137.17K | -184.42K |
| EBITDA Ratio | -3,290.15% | -11,539.44% | -140,655.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.73M | -16.12M | -16.05M | -11.67M | -13.02M | -115.20K | -123.44K | -137.17K | -184.42K |
| Operating Income Ratio | -5,137.06% | -12,142.65% | -141,482.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.79M | 6.22M | -3.86M | 2.13M | -2.22M | 820.86K | 1.70M | -4.70M | -107.31K |
| Income Before Tax | -18.94M | -9.91M | -16.65M | -7.89M | -10.34M | 705.67K | 1.58M | -4.83M | -291.73K |
| Income Before Tax Ratio | -4,694.58% | -7,461.33% | -146,802.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 2.00 | -6.32M | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -18.94M | -3.59M | -16.76M | -8.00M | -10.50M | 705.67K | 1.58M | -4.83M | -291.73K |
| Net Income Ratio | -4,694.58% | -2,700.97% | -147,774.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| EPS Diluted | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| Weighted Avg Shares Out | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
| Weighted Avg Shares Out (Dil) | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
Perimeter Medical Imaging AI announces new milestone for its S-Series OCT system
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) said it has placed its S-Series OCT system in Utah. It is the first commercial placement of its flagship system, the company said in a statement.
Perimeter Medical Imaging AI, Inc. (PYNKF) Q4 2022 Earnings Call Transcript
Perimeter Medical Imaging AI, Inc. (OTCPK:PYNKF) Q4 2022 Earnings Conference Call April 11, 2023 5:00 PM ET Company Participants Jodi Regts - Investor Relations Jeremy Sobotta - Chief Executive Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets...
Perimeter Medical Imaging AI finishes 2022 on strong footing after doubling the commercial installed base of Perimeter S-Series OCT
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) finished the 2022 financial year on a strong footing, with cash and equivalents of nearly US$28.4 million after doubling the commercial installed base of its flagship Perimeter S-Series OCT. The firm's Perimeter S-Series OCT...
Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss 2022 Financial Results and Provide Corporate Update
Hosting Call on Tuesday, April 11th at 5 pm ET TORONTO and DALLAS , April 4, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven...
Perimeter Medical Imaging AI highlights new publication featuring commercial use of Perimeter S-Series OCT
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) announced the publication of a new white paper featuring three case studies involving the commercial use of its Perimeter S-Series Optical Coherence Tomography (OCT) technology. The Perimeter S-Series OCT is an ultra-high-resolution medical imaging tool...
Perimeter Medical Imaging AI makes leadership changes, including appointment of Suzanne Foster as chair of its board of directors
Perimeter Medical Imaging AI Inc (TSX-V:PINK, OTC:PYNKF) has reported leadership changes, including the appointment of Suzanne Foster as chair of its board of directors, effective immediately, and the resignation of its chief financial officer. Perimeter Medical noted that Foster is...
Perimeter Medical Imaging AI reports two new commercial installations of its flagship Perimeter SSeries OCT system
Perimeter Medical Imaging AI Inc (TSX-V:PINK, OTC:PYNKF) has reported two new commercial installations of its flagship Perimeter SSeries OCT system, which were completed prior to year-end. In a statement, Jeremy Sobotta, Perimeter's chief executive officer commented: “I am excited by...
Study validates the use of Perimeter Medical Imaging AI's flagship OCT system for head and neck tissue indications, says Leede Jones
Analysts at Leede Jones noted that a qualitative study in a peer-reviewed research article validates the use of Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) Inc's flagship wide-field Optical Coherence Tomography (WF-OCT) system for other indications, including head and neck tissue....
Perimeter Medical Imaging AI reveals positive study results validating potential use of WF-OCT tech in head and neck surgeries
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF), Inc has announced the publication of a peer-reviewed research article in JAMA Otolaryngology—Head and Neck Surgery, saying the study's findings validate the further exploration of the use of Perimeter's wide-field Optical Coherence Tomography (WF-OCT) technology...
Perimeter Medical Imaging AI, Inc. (PYNKF) Q3 2022 Earnings Call Transcript
Perimeter Medical Imaging AI, Inc. (OTCPK:PYNKF) Q3 2022 Earnings Conference Call November 15, 2022 5:05 PM ET Company Participants Jodi Regts - Investor Relations Jeremy Sobotta - Chief Executive Officer Chris Scott - Chief Financial Officer Conference Call Participants Rahul...
Source: https://incomestatements.info
Category: Stock Reports